NEXGEL, Inc. (NXGL) Stock Forecast

NASDAQ: NXGLAnalyst ratings, price target and estimates.

NXGL analyst forecast

as of October 18, 2026
Analyst consensus
Hold
3.00 / 5 from 1 analysts
Price target
$2.00
average of analyst targets
Upside to target
−64.2%
from the latest close
Next earnings
November 10, 2026
EPS estimate $-4.80
52-week range
$3.00 – $55.60

NXGL analyst ratings

1 analysts
Strong buy
00%
Buy
00%
Hold
1100%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

NXGL price target

Price $5.59Target $2.00
52-week low $3.0052-week high $55.60

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

NXGL earnings per share estimates

NEXGEL, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$4.80−$4.80−$4.80−$1.60−200.0%1
Current fiscal year (2026)−$18.80−$18.80−$18.80−$8.35−125.1%1
Next fiscal year (2027)−$4.40−$4.40−$4.40−$18.80+76.6%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

NXGL revenue estimates

NEXGEL, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$4.2M$4.2M$4.2M—1
Current fiscal year (2026)$15.8M$15.8M$15.8M+38.2%1
Next fiscal year (2027)$24.3M$24.3M$24.3M+53.7%1

NXGL EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

NXGL revenue: reported and forecast

Reported revenueEstimate (average; low–high)

NXGL EPS estimate revisions

NEXGEL, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.80−$0.80−$0.80−$0.80−$4.80+500.0%0 up · 1 down
Current fiscal year (2026)−$2.40−$2.40−$2.40−$2.40−$18.80+683.3%0 up · 1 down
Next fiscal year (2027)$8.00$8.00$8.00$8.00−$4.40−155.0%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

NXGL earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; NXGL beat in 4 of 12.

What analysts expect from NXGL

1 analysts cover NEXGEL; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $2.00, 64.2% below the latest close of $5.59. Analysts expect earnings of −$18.80 per share for 2026, −125.1% from a year earlier. For 2027 the average estimate is −$4.40 per share on revenue of $24.3 million. NEXGEL beat the EPS estimate in 4 of the last 12 quarters.

Related: NXGL income statement, NXGL key metrics, NXGL chart. See the NXGL stock overview for the latest quote and news.

NXGL forecast FAQ

What is NEXGEL's price target?

The average analyst price target for NEXGEL is $2.00, 64.2% below the latest close of $5.59.

Is NEXGEL a buy, hold or sell?

Of 1 analysts covering NEXGEL, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

What is NEXGEL's EPS forecast?

Analysts forecast −$18.80 per share for 2026 (range −$18.80 to −$18.80); for 2027 the estimate is −$4.40.

What is NEXGEL's revenue forecast?

The average revenue estimate for 2026 is $15.8 million, growth of 38.2%; for 2027 it is $24.3 million.

When does NEXGEL report earnings?

NEXGEL is expected to report results for the quarter ending September 30, 2026 on November 10, 2026 before the market opens; the EPS estimate is $-4.80.

Does NEXGEL usually beat earnings estimates?

NEXGEL reported EPS at or above the analyst estimate in 4 of the last 12 quarters.

Medical Instruments & Supplies: forecast